0000950123-11-049431.txt : 20110512
0000950123-11-049431.hdr.sgml : 20110512
20110512161538
ACCESSION NUMBER: 0000950123-11-049431
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110331
FILED AS OF DATE: 20110512
DATE AS OF CHANGE: 20110512
EFFECTIVENESS DATE: 20110512
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VHCP Management, LLC
CENTRAL INDEX KEY: 0001479355
IRS NUMBER: 263477966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14329
FILM NUMBER: 11835998
BUSINESS ADDRESS:
STREET 1: 3340 HILLVIEW AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 6504753734
MAIL ADDRESS:
STREET 1: 3340 HILLVIEW AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94304
13F-HR
1
w82689e13fvhr.txt
FORM 13F-HR
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2011
Check here if Amendment [ ]; Amendment Number: ______________
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holding entries.
Institutional Investment Manager Filing this Report:
Name: VHCP Management, LLC
Address: 3340 Hillview Avenue
Palo Alto, California 94304
Form 13F File Number: 28- ___________
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: David Stepp
Title: General Counsel, VR Management, LLC
Phone: (650) 561-9580
Signature, Place, and Date of Signing:
Palo Alto, California May 12, 2011
-------------------------------------
[Signature]
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: Thirteen (13)
Form 13F Information Table Value Total: $187,335,000
List of Other Included Managers: None
FORM 13F INFORMATION TABLE
Voting Authority
TITLE OF VALUE SHARES / SH / PUT / INVESTMENT OTHER ---------------------
NAME OF ISSUER CLASS CUSIP (X$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
-------------- -------- ----------- -------- --------- ---- ----- ---------- -------- --------- ------ ----
ACADIA Pharmaceuticals, Inc. COM 004225 10 8 5,428 3,350,785 SH N/A Sole N/A 3,350,785 N/A N/A
Affymax, Inc. COM 00826A 10 9 7,925 1,350,000 SH N/A Sole N/A 1,350,000 N/A N/A
Anacor Pharmaceuticals, Inc. COM 032420 10 1 12,927 2,000,000 SH N/A Sole N/A 2,000,000 N/A N/A
Ardea Biosciences, Inc. COM 03969P 10 7 14,609 509,205 SH N/A Sole N/A 509,205 N/A N/A
Chelsea Therapeutics International,
Inc. COM 163428 10 5 15,144 3,903,170 SH N/A Sole N/A 3,903,170 N/A N/A
Depomed, Inc. COM 249908 10 4 14,772 1,471,300 SH N/A Sole N/A 1,471,300 N/A N/A
Durect Corp. COM 266605 10 4 16,000 4,444,444 SH N/A Sole N/A 4,444,444 N/A N/A
Inspire Pharmaceuticals, Inc. COM 457733 10 3 5,140 1,298,025 SH N/A Sole N/A 1,298,025 N/A N/A
Ironwood Pharmaceuticals, Inc. COM 46333X 10 8 33,552 2,400,000 SH N/A Sole N/A 2,400,000 N/A N/A
Medivation, Inc. COM 58501N 10 1 4,990 267,700 SH N/A Sole N/A 267,700 N/A N/A
Neurocrine Biosciences, Inc. COM 64125C 10 9 35,872 4,726,189 SH N/A Sole N/A 4,726,189 N/A N/A
Novavax, Inc. COM 670002 10 4 5,217 2,014,200 SH N/A Sole N/A 2,014,200 N/A N/A
NPS Pharmaceuticals, Inc. COM 62936P 10 3 15,759 1,645,000 SH N/A Sole N/A 1,645,000 N/A N/A